| Cystic renal cell carcinoma: a report on outcomes of surgery and active surveillance in patients retrospectively identified on pretreatment imaging M Kashan, M Ghanaat, AM Hötker, C Duzgol, A Sanchez, RG DiNatale, ... The Journal of urology 200 (2), 275-282, 2018 | 45 | 2018 |
| Accelerating prostate diffusion-weighted MRI using a guided denoising convolutional neural network: retrospective feasibility study EA Kaye, EA Aherne, C Duzgol, I Häggström, E Kobler, Y Mazaheri, ... Radiology: Artificial Intelligence 2 (5), e200007, 2020 | 38 | 2020 |
| DyeFreeNet: Deep virtual contrast CT synthesis J Liu, Y Tian, AM Ağıldere, KM Haberal, M Coşkun, C Duzgol, O Akin Simulation and Synthesis in Medical Imaging: 5th International Workshop …, 2020 | 20 | 2020 |
| Clinical and genomic landscape of FGFR3-altered urothelial carcinoma and treatment outcomes with erdafitinib: a real-world experience BJ Guercio, M Sarfaty, MY Teo, N Ratna, C Duzgol, SA Funt, CH Lee, ... Clinical Cancer Research 29 (22), 4586-4595, 2023 | 19 | 2023 |
| Associations between pretreatment body composition features and clinical outcomes among patients with metastatic clear cell renal cell carcinoma treated with immune checkpoint … Y Ged, A Sanchez, S Patil, A Knezevic, E Stein, S Petruzella, K Weiss, ... Clinical Cancer Research 28 (23), 5180-5189, 2022 | 19 | 2022 |
| Systemic therapy for advanced clear cell renal cell carcinoma after discontinuation of immune-oncology and VEGF targeted therapy combinations Y Ged, R Gupta, C Duzgol, A Knezevic, N Shapnik, R Kotecha, MH Voss, ... BMC urology 20, 1-8, 2020 | 15 | 2020 |
| Progression-free survival after second line of therapy for metastatic clear cell renal cell carcinoma in patients treated with first-line immunotherapy combinations KN Fitzgerald, C Duzgol, A Knezevic, N Shapnik, R Kotecha, DH Aggen, ... European urology 83 (3), 195-199, 2023 | 12 | 2023 |
| Virtual contrast enhancement for CT scans of abdomen and pelvis J Liu, Y Tian, C Duzgol, O Akin, AM Ağıldere, KM Haberal, M Coşkun Computerized Medical Imaging and Graphics 100, 102094, 2022 | 11 | 2022 |
| Preoperative nomogram predicting 12-year probability of metastatic renal cancer–evaluation in a contemporary cohort R Mano, C Duzgol, M Ganat, DA Goldman, KA Blum, AW Silagy, ... Urologic Oncology: Seminars and Original Investigations 38 (11), 853. e1-853. e7, 2020 | 10 | 2020 |
| Sarcomatoid renal cell carcinoma: MRI features and their association with survival M Cheng, C Duzgol, TH Kim, S Ghafoor, AS Becker, PI Causa Andrieu, ... Cancer Imaging 23 (1), 16, 2023 | 9 | 2023 |
| Somatic mutations as preoperative predictors of metastases in patients with localized clear cell renal cell carcinoma–an exploratory analysis R Mano, C Duzgol, M Ganat, DA Goldman, KA Blum, AW Silagy, ... Urologic Oncology: Seminars and Original Investigations 39 (11), 791. e17 …, 2021 | 7 | 2021 |
| Systemic therapy for advanced clear cell renal cell carcinoma (ccRCC) after progression on immune-oncology plus VEGF targeted therapy combinations (IO-VEGF). Y Ged, R Gupta, C Duzgol, N Shapnik, A Redzematovic, R Kotecha, ... Journal of Clinical Oncology 37 (15_suppl), 4576-4576, 2019 | 6 | 2019 |
| Bilateral sudden sensorineural hearing loss caused by leptomeningeal carcinomatosis: case report and review M Öztürk, K İla, C Düzgöl, G Akansel, A Almaç Kulak Burun Bogaz Ihtis Derg 24 (5), 287-291, 2014 | 6 | 2014 |
| Characterization Of Kidney Stones With Imaging Modalities: Twinkling Artifact In Color Doppler Ultrasound And Density In Non-Contrast-Enhanced CT Ç İmamoğlu, FGB İmamoğlu, A Gök, İH Bozkurt, C Düzgöl, M Tola, ... The Journal of Tepecik Education and Research Hospital 26 (2), 120-126, 2016 | 4 | 2016 |
| An evaluation of the role of tumor load in cytoreductive nephrectomy AW Silagy, C Duzgol, J Marcon, RG DiNatale, R Mano, KA Blum, ... Canadian Urological Association Journal 14 (12), E625, 2020 | 3* | 2020 |
| Tiroid Nodüllerinde Ultrasonografi Eşliğinde İnce İğne Aspirasyon Sitolojisi: Sitohistolojik Korelasyon Ç İmamoğlu, FG İmamoğlu, H Dizen, A Argon, ZH Adıbelli, BP Cengiz, ... Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi 2 (3), 7-11, 2015 | 2 | 2015 |
| Impact of sarcomatoid features on treatment outcomes in metastatic clear cell renal cell carcinoma treated with first-line immunotherapy combinations. KN Fitzgerald, C Duzgol, A Knezevic, N Shapnik, RR Kotecha, DH Aggen, ... Journal of Clinical Oncology 41 (6_suppl), 687-687, 2023 | 1 | 2023 |
| PD59-09 OUTCOMES OF CYTOREDUCTIVE NEPHRECTOMY FOLLOWED BY ACTIVE SURVEILLANCE IN METASTATIC RENAL CELL CARCINOMA S Khaleel, A Silagy, C Duzgol, R Kotecha, P Rappold, R Motzer, P Russo, ... Journal of Urology 207 (Supplement 5), e1022, 2022 | 1 | 2022 |
| The spinal distribution of metastatic renal cell carcinoma: support for locoregional rather than arterial hematogenous mode of early bony dissemination K Attalla, C Duzgol, L McLaughlin, J Flynn, I Ostrovnaya, P Russo, ... Urologic Oncology: Seminars and Original Investigations 39 (3), 196. e9-196. e14, 2021 | 1 | 2021 |
| Association of body mass index (BMI) with clinical outcomes in 203 metastatic clear cell renal cell carcinoma (ccRCC) patients (pts) treated with immuno-oncology (IO) agents. Y Ged, CH Lee, A Sanchez, C Duzgol, J Chaim, MI Carlo, A Foster, O Akin, ... Journal of Clinical Oncology 37 (15_suppl), e16103-e16103, 2019 | 1 | 2019 |
A Ari HakimiMemorial Sloan Kettering Cancer CenterВерификована је имејл адреса на mskcc.org
